Aadi Bioscience, Inc. (NASDAQ:AADI) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET
Company Participants
Marcy Graham - Senior Vice President, Investor Relations and Corporate Communications
Scott Giacobello - CFO
Dave Lennon - President and CEO
Loretta Itri - Chief Medical Officer
Conference Call Participants
Boris Peaker - Cowen
Joe Catanzaro - Piper Sandler
Roger Song - Jefferies
Ahu Demir - Ladenburg Thalmann
Operator
Good day, and thank you for standing by. Welcome to the Aadi Bioscience Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. [Operator Instructions] Please be advised, today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, Marcy Graham, Senior Vice President of Investor Relations and Corporate Communications, Aadi Bioscience. Ms. Graham, please go ahead.
Marcy Graham
Thank you. Good morning and welcome to the Aadi Bioscience conference call to provide an operational update and review results for the third quarter 2023. Joining me on the call today: Dr. David Lennon, our President and CEO; Scott Giacobello, our CFO; and our Chief Medical Officer, Dr. Loretta Itri.
Today we will provide an overview of operational activity and financial results for the third quarter of 2023 and an update on our PRECISION 1 trial and clinical development plans going forward. We will open the line for questions at the end of the call, following closing comments.
A quick reminder that statements made on the call today will include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in the Risk Factors section of our annual and quarterly filings with the Securities and Exchange Commission, which can be found at www.sec.gov or on our website at www.aadibio.com.
In addition, any forward-looking statements made on this call represent our views only as of today, November 8th, 2023, and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements.
With that, I will turn the call over to our CFO, Scott Giacobello for his opening statements. Scott?
Scott Giacobello
Thank you, Marcy and good morning, everyone. Thank you for joining us today to review our financial and operational results for the third quarter of 2023. Before we discuss our progress in the third quarter, an activity is currently underway, I would like to take this opportunity to introduce Dave Lennon, who joined us as President and CEO at the start of the fourth quarter.